Computational modeling of structure-function of g protein-coupled receptors with applications for drug design.
暂无分享,去创建一个
W. Goddard | Youyong Li | W A Goddard | Y Y Li | T J Hou | W. A. Goddard | Y. Li | T. Hou
[1] W. Goddard,et al. Structure of polyamidoamide dendrimers up to limiting generations: a mesoscale description. , 2009, The Journal of chemical physics.
[2] R. Stevens,et al. The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist , 2008, Science.
[3] Oliver P. Ernst,et al. Crystal structure of opsin in its G-protein-interacting conformation , 2008, Nature.
[4] Patrick Scheerer,et al. Crystal structure of the ligand-free G-protein-coupled receptor opsin , 2008, Nature.
[5] Tomas Perez-Acle,et al. Computational modeling study of functional microdomains in cannabinoid receptor type 1. , 2008, Bioorganic & medicinal chemistry.
[6] Nagarajan Vaidehi,et al. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation. , 2008, Biophysical journal.
[7] Youyong Li,et al. PREDICTION OF THE STRUCTURE OF G-PROTEIN COUPLED RECEPTOR WITH APPLICATION FOR DRUG DESIGN , 2008 .
[8] R. Stevens,et al. High-Resolution Crystal Structure of an Engineered Human β2-Adrenergic G Protein–Coupled Receptor , 2007, Science.
[9] Abdelazize Laoui,et al. Prediction of the 3D structure and dynamics of human DP G-protein coupled receptor bound to an agonist and an antagonist. , 2007, Journal of the American Chemical Society.
[10] R. Zauhar,et al. Molecular dynamics of a biophysical model for beta2-adrenergic and G protein-coupled receptor activation. , 2006, Journal of molecular graphics & modelling.
[11] Francesca Fanelli,et al. Inactive and active states and supramolecular organization of GPCRs: insights from computational modeling , 2006, J. Comput. Aided Mol. Des..
[12] Youyong Li,et al. Continuous self-avoiding walk with application to the description of polymer chains. , 2006, The journal of physical chemistry. B.
[13] T. Schwartz,et al. Molecular mechanism of 7TM receptor activation--a global toggle switch model. , 2006, Annual review of pharmacology and toxicology.
[14] Francesca Fanelli,et al. Computational modeling approaches to structure-function analysis of G protein-coupled receptors. , 2005, Chemical reviews.
[15] Gunnar von Heijne,et al. Transmembrane helices before, during, and after insertion. , 2005, Current opinion in structural biology.
[16] G. Schertler. Structure of rhodopsin and the metarhodopsin I photointermediate. , 2005, Current opinion in structural biology.
[17] Leonardo Pardo,et al. A three-dimensional pharmacophore model for 5-hydroxytryptamine6 (5-HT6) receptor antagonists. , 2005, Journal of medicinal chemistry.
[18] M. Lohse,et al. Molecular basis of inverse agonism in a G protein–coupled receptor , 2005, Nature chemical biology.
[19] Giuseppe Nano,et al. 2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors. , 2005, Journal of medicinal chemistry.
[20] M. Mor,et al. Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models. , 2005, Journal of medicinal chemistry.
[21] Elizabeth Buck,et al. Disulfide trapping to localize small-molecule agonists and antagonists for a G protein-coupled receptor. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[22] Riccardo Petrelli,et al. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists. , 2005, Journal of medicinal chemistry.
[23] K. Katoh,et al. MAFFT version 5: improvement in accuracy of multiple sequence alignment , 2005, Nucleic acids research.
[24] Francesca Deflorian,et al. Combined target-based and ligand-based drug design approach as a tool to define a novel 3D-pharmacophore model of human A3 adenosine receptor antagonists: pyrazolo[4,3-e]1,2,4-triazolo[1,5-c]pyrimidine derivatives as a key study. , 2005, Journal of medicinal chemistry.
[25] Peter Gmeiner,et al. Modeling the similarity and divergence of dopamine D2-like receptors and identification of validated ligand-receptor complexes. , 2005, Journal of medicinal chemistry.
[26] W. Millard,et al. Structural characterization and pharmacology of a potent (Cys101-Cys119, Cys110-Cys117) bicyclic agouti-related protein (AGRP) melanocortin receptor antagonist. , 2004, Journal of medicinal chemistry.
[27] R. Kiss,et al. Homology modelling and binding site mapping of the human histamine H1 receptor. , 2004, European journal of medicinal chemistry.
[28] Richard A Friesner,et al. An Automatic Method for Predicting Transmembrane Protein Structures Using Cryo-em and Evolutionary Data , 2004 .
[29] K. Jacobson,et al. Architecture of P2Y nucleotide receptors: structural comparison based on sequence analysis, mutagenesis, and homology modeling. , 2004, Journal of medicinal chemistry.
[30] W. Goddard,et al. Selectivity and specificity of substrate binding in methionyl‐tRNA synthetase , 2004, Protein Science.
[31] Nagarajan Vaidehi,et al. Predicted 3-D structures for mouse I7 and rat I7 olfactory receptors and comparison of predicted odor recognition profiles with experiment. , 2004, Chemical senses.
[32] D. Major,et al. Molecular recognition in purinergic receptors. 1. A comprehensive computational study of the h-P2Y1-receptor. , 2004, Journal of medicinal chemistry.
[33] Christopher A Reynolds,et al. Toward the active conformations of rhodopsin and the β2‐adrenergic receptor , 2004, Proteins.
[34] S. Moro,et al. 1,2,4-triazolo[4,3-a]quinoxalin-1-one moiety as an attractive scaffold to develop new potent and selective human A3 adenosine receptor antagonists: synthesis, pharmacological, and ligand-receptor modeling studies. , 2004, Journal of medicinal chemistry.
[35] Kurt Kristiansen,et al. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function. , 2004, Pharmacology & therapeutics.
[36] Antti Poso,et al. Development of a 3D model for the human cannabinoid CB1 receptor. , 2004, Journal of medicinal chemistry.
[37] Patrick Jimonet,et al. Strategies for designing GPCR-focused libraries and screening sets. , 2004, Current opinion in drug discovery & development.
[38] Nagarajan Vaidehi,et al. Making sense of olfaction through predictions of the 3-D structure and function of olfactory receptors. , 2004, Chemical senses.
[39] Andrzej Wilczynski,et al. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. , 2004, Journal of medicinal chemistry.
[40] Peter L. Freddolino,et al. The predicted 3D structure of the human D2 dopamine receptor and the binding site and binding affinities for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[41] Didier Rognan,et al. High-Throughput Modeling of Human G-Protein Coupled Receptors: Amino Acid Sequence Alignment, Three-Dimensional Model Building, and Receptor Library Screening , 2004, J. Chem. Inf. Model..
[42] Francesca Fanelli,et al. Synthesis, Screening, and Molecular Modeling of New Potent and Selective Antagonists at the α1d Adrenergic Receptor , 2004 .
[43] Peter L. Freddolino,et al. Predicted 3D structure for the human beta 2 adrenergic receptor and its binding site for agonists and antagonists. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[44] Nagarajan Vaidehi,et al. HierVLS hierarchical docking protocol for virtual ligand screening of large-molecule databases. , 2004, Journal of medicinal chemistry.
[45] Stephen C Peiper,et al. Lipid Bilayer Simulations of CXCR4 with Inverse Agonists and Weak Partial Agonists* , 2003, Journal of Biological Chemistry.
[46] L. Pardo,et al. Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives. , 2003, Journal of medicinal chemistry.
[47] Kenneth A Jacobson,et al. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists. , 2003, Journal of medicinal chemistry.
[48] Didier Rognan,et al. Identification of the Binding Sites of the SR49059 Nonpeptide Antagonist into the V1a Vasopressin Receptor Using Sulfydryl-reactive Ligands and Cysteine Mutants as Chemical Sensors* , 2003, Journal of Biological Chemistry.
[49] William A. Goddard,et al. Fidelity of Phenylalanyl-tRNA Synthetase in Binding the Natural Amino Acids , 2003 .
[50] I. Forbes,et al. CCR2: characterization of the antagonist binding site from a combined receptor modeling/mutagenesis approach. , 2003, Journal of medicinal chemistry.
[51] Adrian A Canutescu,et al. Access the most recent version at doi: 10.1110/ps.03154503 References , 2003 .
[52] Simona Collina,et al. Synthesis, biological evaluation, and receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as kappa-opioid receptor agonists endowed with antinociceptive and antiamnesic activity. , 2003, Journal of medicinal chemistry.
[53] Krzysztof Palczewski,et al. Sequence analyses of G-protein-coupled receptors: similarities to rhodopsin. , 2003, Biochemistry.
[54] Krzysztof Palczewski,et al. Role of the conserved NPxxY(x)5,6F motif in the rhodopsin ground state and during activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[55] Wely B. Floriano,et al. Interaction of e. coli outer‐membrane protein A with sugars on the receptors of the brain microvascular endothelial cells , 2002, Proteins.
[56] Gert Vriend,et al. GPCRDB information system for G protein-coupled receptors , 2003, Nucleic Acids Res..
[57] Nagarajan Vaidehi,et al. Virtual screening for binding of phenylalanine analogues to phenylalanyl-tRNA synthetase. , 2002, Journal of the American Chemical Society.
[58] Shigeyuki Yokoyama,et al. Conformation of ligands bound to the muscarinic acetylcholine receptor. , 2002, Molecular pharmacology.
[59] Molecular Structure and Function of 7TM G- Protein- Coupled Receptors , 2002 .
[60] Kenneth A. Jacobson,et al. Structural Determinants of A3 Adenosine Receptor Activation: Nucleoside Ligands at the Agonist/Antagonist Boundary , 2002 .
[61] S. Moro,et al. Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist. , 2002, Journal of medicinal chemistry.
[62] K. Katoh,et al. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. , 2002, Nucleic acids research.
[63] S. Sagan,et al. Involvement of the Second Extracellular Loop (E2) of the Neurokinin-1 Receptor in the Binding of Substance P , 2002, The Journal of Biological Chemistry.
[64] T. Sakmar,et al. Evidence that helix 8 of rhodopsin acts as a membrane-dependent conformational switch. , 2002, Biochemistry.
[65] K. Jacobson,et al. Identification by Site-directed Mutagenesis of Residues Involved in Ligand Recognition and Activation of the Human A3 Adenosine Receptor* , 2002, The Journal of Biological Chemistry.
[66] W. Goddard,et al. Structure-based design of mutant Methanococcus jannaschii tyrosyl-tRNA synthetase for incorporation of O-methyl-l-tyrosine , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] W. Goddard,et al. Mechanism for antibody catalysis of the oxidation of water by singlet dioxygen , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[68] Barbara Cacciari,et al. Synthesis, biological activity, and molecular modeling investigation of new pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives as human A(3) adenosine receptor antagonists. , 2002, Journal of medicinal chemistry.
[69] J. Wess,et al. Conformational Changes That Occur during M3Muscarinic Acetylcholine Receptor Activation Probed by the Use of an in Situ Disulfide Cross-linking Strategy* , 2002, The Journal of Biological Chemistry.
[70] K. Palczewski,et al. Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor , 2002, Chembiochem : a European journal of chemical biology.
[71] J. Klein-Seetharaman,et al. Structure and function in rhodopsin: mapping light-dependent changes in distance between residue 316 in helix 8 and residues in the sequence 60-75, covering the cytoplasmic end of helices TM1 and TM2 and their connection loop CL1. , 2001, Biochemistry.
[72] K. Jacobson,et al. Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. , 2001, Journal of medicinal chemistry.
[73] E. Meng,et al. Receptor activation: what does the rhodopsin structure tell us? , 2001, Trends in pharmacological sciences.
[74] J. Ballesteros,et al. Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors. , 2001, Molecular pharmacology.
[75] T. Schwartz,et al. Partial agonism through a zinc-Ion switch constructed between transmembrane domains III and VII in the tachykinin NK(1) receptor. , 2000, Molecular pharmacology.
[76] R. Lefkowitz. The superfamily of heptahelical receptors , 2000, Nature Cell Biology.
[77] U. Gether. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. , 2000, Endocrine reviews.
[78] T. Schwartz,et al. Conversion of agonist site to metal-ion chelator site in the beta(2)-adrenergic receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[79] P Ghanouni,et al. Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6. , 1999, Molecular pharmacology.
[80] Andrei L. Lomize,et al. Structural organization of G-protein-coupled receptors , 1999, J. Comput. Aided Mol. Des..
[81] C Altenbach,et al. Structural features and light-dependent changes in the sequence 306-322 extending from helix VII to the palmitoylation sites in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.
[82] J. Klein-Seetharaman,et al. Structural features and light-dependent changes in the sequence 59-75 connecting helices I and II in rhodopsin: a site-directed spin-labeling study. , 1999, Biochemistry.
[83] William A. Goddard,et al. PROTEIN FOLD DETERMINATION FROM SPARSE DISTANCE RESTRAINTS : THE RESTRAINED GENERIC PROTEIN DIRECT MONTE CARLO METHOD , 1999 .
[84] J. Bockaert,et al. Molecular tinkering of G protein‐coupled receptors: an evolutionary success , 1999, The EMBO journal.
[85] S. Satoh,et al. The key amino acid residue of prostaglandin EP3 receptor for governing G protein association and activation steps. , 1999, Biochemical and biophysical research communications.
[86] M. Caron,et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. , 1999, Science.
[87] D. Farrens,et al. Conformational Changes in Rhodopsin , 1999, The Journal of Biological Chemistry.
[88] G. Schertler,et al. Characterisation of an improved two-dimensional p22121 crystal from bovine rhodopsin. , 1998, Journal of molecular biology.
[89] A. Lomize,et al. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. , 1998, Biophysical journal.
[90] S. Sealfon,et al. Rhodopsin-family receptors associate with small G proteins to activate phospholipase D , 1998, Nature.
[91] Juan Jesús Pérez,et al. BUNDLE: A program for building the transmembrane domains of G-protein-coupled receptors , 1998, J. Comput. Aided Mol. Des..
[92] Heidi E. Hamm,et al. The Many Faces of G Protein Signaling* , 1998, The Journal of Biological Chemistry.
[93] J. Baldwin,et al. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.
[94] Todd J. A. Ewing,et al. Critical evaluation of search algorithms for automated molecular docking and database screening , 1997, J. Comput. Chem..
[95] A. Lomize,et al. The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. , 1997, Biophysical journal.
[96] M. Cocchi,et al. Alpha 1-adrenoceptor subtype selectivity: molecular modelling and theoretical quantitative structure-affinity relationships. , 1997, Bioorganic & medicinal chemistry.
[97] H. Khorana,et al. Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.
[98] Stephen H. White,et al. Experimentally determined hydrophobicity scale for proteins at membrane interfaces , 1996, Nature Structural Biology.
[99] O. Lichtarge,et al. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.
[100] H. Khorana,et al. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin: a site-directed spin-labeling study. , 1996, Biochemistry.
[101] G. Loew,et al. A 3D model of the δ opioid receptor and ligand-receptor complexes , 1996 .
[102] Martin J. Lohse,et al. Mutations of Tyr326 in the β2-adrenoceptor disrupt multiple receptor functions , 1996 .
[103] Abhinandan Jain,et al. Constant temperature constrained molecular dynamics: The Newton-Euler inverse mass operator method , 1996 .
[104] M. Menziani,et al. Synthesis, biological evaluation, and quantitative receptor docking simulations of 2-[(acylamino)ethyl]-1,4-benzodiazepines as novel tifluadom-like ligands with high affinity and selectivity for kappa-opioid receptors. , 1996, Journal of medicinal chemistry.
[105] M C Peitsch,et al. Automated modelling of the transmembrane region of G-protein coupled receptor by Swiss-model. , 1996, Receptors & channels.
[106] P Herzyk,et al. Automated method for modeling seven-helix transmembrane receptors from experimental data. , 1995, Biophysical journal.
[107] B. Kobilka,et al. Fluorescent labeling of purified beta 2 adrenergic receptor. Evidence for ligand-specific conformational changes. , 1995, The Journal of biological chemistry.
[108] J. Ballesteros,et al. [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .
[109] W. Greenlee,et al. Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.
[110] Marina Cocchi,et al. The heuristic-direct approach to theoretical quantitative structure activity relationship analysis of α1- adrenoceptor ligands , 1994 .
[111] T. Schwartz,et al. Differentiation between binding sites for angiotensin II and nonpeptide antagonists on the angiotensin II type 1 receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[112] C. Strader,et al. Localization of the ligand binding site of the neurokinin-1 receptor: interpretation of chimeric mutations and single-residue substitutions. , 1994, Molecular pharmacology.
[113] T L Blundell,et al. The evolution and structure of aminergic G protein-coupled receptors. , 1994, Receptors & channels.
[114] Marina Cocchi,et al. The heuristic-direct approach to quantitative structure-activity relationship analysis , 1993 .
[115] S. Nakanishi,et al. Different binding epitopes on the NK1 receptor for substance P and a non-peptide antagonist , 1993, Nature.
[116] C. Strader,et al. Localization of agonist and antagonist binding domains of the human neurokinin-1 receptor. , 1992, The Journal of biological chemistry.
[117] C. Strader,et al. The extracellular domain of the neurokinin-1 receptor is required for high-affinity binding of peptides. , 1992 .
[118] S. Chaki,et al. Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.
[119] L. F. Kolakowski,et al. Expression cloning and characterization of the canine parietal cell gastrin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[120] W. C. Probst,et al. Sequence alignment of the G-protein coupled receptor superfamily. , 1992, DNA and cell biology.
[121] Frank McCormick,et al. The GTPase superfamily: conserved structure and molecular mechanism , 1991, Nature.
[122] S. L. Mayo,et al. DREIDING: A generic force field for molecular simulations , 1990 .
[123] G Vriend,et al. WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.
[124] C. Strader,et al. Structural basis of β‐adrenergic receptor function , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[125] Irving S. Sigal,et al. Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core , 1987, Nature.